Tritiated LSD binding in frontal cortex in schizophrenia

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Previous research suggested reduced serotonin receptor binding in schizophrenia.
• This interpretation was based on tritiated LSD binding studies in the frontal cortex.
• Potential confounding factors like residual neuroleptic medication were not fully addressed.

Purpose of the Study:

• To re-evaluate tritiated LSD binding in the frontal cortex of schizophrenic patients.
• To investigate the influence of neuroleptic medication on LSD binding.
• To clarify the status of serotonin receptors in schizophrenia.

Main Methods:

• Scatchard analysis of tritiated LSD binding in the frontal cortex of 13 schizophrenic patients and 8 control brains.
• Comparison of binding characteristics between patient and control groups.
• Investigation of LSD binding in brains of patients with documented neuroleptic-free periods.

Main Results:

• No significant decrease in tritiated LSD binding was observed in schizophrenic brains compared to controls.
• Residual neuroleptic medication was identified as a potential confounder affecting previous findings.
• Significantly increased tritiated LSD binding was found in the brains of five neuroleptic-free schizophrenic patients.

Conclusions:

• The study challenges the hypothesis of reduced serotonin receptor numbers in schizophrenia.
• Neuroleptic medication may artificially lower observed LSD binding.
• Further research with larger samples is needed to confirm increased LSD binding in neuroleptic-free schizophrenic patients.